Cancer clones evolution in some forms of haemoblastosis

S N Kolubaeva; A V Novitsky; N A Victorova; O P Krasnova; A M Ivanov

doi:10.17816/MAJ11165-69

Medical academic journal ›› 2011, Vol. 11 ›› Issue (1) : 65 -69. DOI: 10.17816/MAJ11165-69

Articles

research-article

Cancer clones evolution in some forms of haemoblastosis

Author information +

History +

PDF

Abstract

The process of cancer clones evolution in haemoblastosis is going in two directions. The first direction comprises development of independent clones each of them accumulating specific injuries not find in other clones. The second direction consists in one initial clone becoming more complex by addition of new injuries. Both directions may be explained by high genetic unstability of the cells. Haematological cancer may have origin in normal stem cells and in normal precursor cells as it was shown for some forms of leucosis.

Keywords

clones evolution / lymphoproliferative diseases / peripheral blood lymphocytes / chromosome injuries

Cite this article

Download citation ▾

S N Kolubaeva, A V Novitsky, N A Victorova, O P Krasnova, A M Ivanov. Cancer clones evolution in some forms of haemoblastosis. Medical academic journal, 2011, 11(1): 65-69 DOI:10.17816/MAJ11165-69

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Kakarala М., Wicha M.S. Cancer stem cells: Implications for cancer treatment and prevention // Cancer J. 2007. Vol. 13. № 5. P. 271-274.

[2]	Holden C. Stem cells. Reprogramming, take two // Sience. 2007. № 316. P. 1404.

[3]	Dontn G., Liu S., Wicha M.S. Stem cells in mammary development and carcinogenesis. Implications for prevention and treatment // Stem Cell Rev. 2005. Vol. 1. P 207-214.

[4]	Wodarz A., Gonsales C. Connecting cancer to asym- metryc division of stem cells // Cell. 2006. Vol. 124. №24. P. 1121-1123.

[5]	Ting X., Li L. Stem cells and their niche: an inseparable relationship // Development. 2007. № 134. P 2001- 2006.

[6]	Li L., Xie T. Stem cells niche: structure and function // Ann. Rev. Cell. Dev. Biol. 2005. № 21. P 605-621.

[7]	Burkert J., Wright N., Alison M. Stem cells and cancer: an intimate relationship // J. Pathol. 2006. № 209. P 287-297.

[8]	Wang J.C., Dick J.E. Cancer stem cells: lessons from leukemia И Trends Cell Biol. 2005. № 15. P. 494- 501.

[9]	Delerba P Cho R.W., Clarke M.F. Cancer stem cells: models and concepts // Ann. Rev. Med. 2007. № 58. P. 267-284.

[10]	Polyak R., Hahn W.C. Roots and stems: Stem cells in cancer//Nat. Med. 2006. № 12. P. 296-300.

[11]	Богданов A.H., Саржевский В.О., Колюбаева С.Н. и др. Случай острого лимфобластного лейкоза с транслокацией t(9;22) и несколькими дополнительными перестройками // Гематол. и трансфузиол. 2008. Т. 53. № 3. С. 35-38.

[12]	An International System for Human Cytogenetic Nomenclature // Recommendations of International Standing Commitee on Human Cytogenetic Nomenclature / Eds. L. Shaffer, N. Tommerup. Basel: S. Karger, 2005.

[13]	Lambrechts A.C., Hupkes P.E., Dorssers L.C., van’t Veer M.B. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non- Hodgkin’s lymphoma // Blood. 1993. Vol. 82. № 8. P.2510-2516.